CompoAtlas

Focus Formula

Focus Formula, licence 80037847: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Lifeagen Biosciences of Florida, Inc. dba Nu-Life North America
NPN or DIN-HM
80037847
Status
Active licence
Licence date
28 November 2012
Revision date
Not provided
Form
Caplet
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Phosphatidylcholine

Source : Lecithin

24.0 mgNot calculated
phosphatidyléthanolamine

Source : Lecithin

20.0 mgNot calculated
[5R-(5alpha,9beta,11E)]-5-Amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-5,9-methanocycloocta[b]pyridin-2(1H)-one

Source : Parties aériennes

50.0 mcgNot calculated
Ginkgo biloba

Source : Leaves (standardized extract)

Extraction ratio : 50:1

Dry plant equivalent : 2000 mg

Potency : 24.0 % Ginkgo flavone glycosides

40.0 mgNot calculated
Ginkgo biloba

Source : Leaves (standardized extract)

Potency : 6.0 % Terpene lacones

Not specifiedNot calculated
Choline

Source : Bitartrate de choline

62.5 mgNot calculated
Vitamine E

Source : Succinate de d-alpha tocophéryle

Potency : 15.0 UI

10.05 mg ATNot calculated
Vitamine B6

Source : Chlorhydrate de pyridoxine

5.0 mgNot calculated
Eleutherococcus senticosus

Source : Root (standardized extract)

Potency : 0.8 % Eleutherosides

50.0 mgNot calculated
phosphatidylinositol

Source : Lecithin

14.0 mgNot calculated
(3alpha,16alpha)-Eburnamenine-14-carboxylic acid ethyl ester2.5 mgNot calculated

Non-medicinal ingredients

Croscarmellose de sodium, Acide stéarique, phosphate de dicalcium, Stéarate de magnésium végétal, Dioxyde de silicium, Microcrystalline cellulose, Pharmaceutical Glaze

PopulationAgeQuantity per servingFrequency
AdultesNot specified1.0 Caplet2.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to enhance cognitive function in adults. Helps to enhance memory in adults. Helps to support peripheral circulation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80037847

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line